What is this medicine?
RASBURICASE (ras BURE i kase) breaks down uric acid in the blood. It is used to prevent and to treat high levels of uric acid caused by cancer treatment.
How should I use this medicine?
This medicine is for infusion into a vein. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 1 month old for selected conditions, precautions do apply.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
blue color to lips or nailbeds
chest pain, tightness
fast, irregular heartbeat
feeling faint or lightheaded, falls
low blood pressure
unusually weak or tired
yellowing of the eyes or skin
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
What may interact with this medicine?
Interactions have not been studied.
Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
What if I miss a dose?
This does not apply.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
history of anemia
history of blood transfusion
an unusual or allergic reaction to rasburicase, yeast, mannitol, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine. You will need to have regular blood tests during your treatment.
Do not breast-feed an infant while taking this medicine or for 2 weeks after stopping it.